Combined use of dexmedetomidine and nalbuphine in laparoscopic radical gastrectomy for gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-7)

Sum=132

Publishing Process of This Article

Item

Count

Browse

Download

Sum=10

Jul 15, 2024 (publication date) through Jul 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2952-2959
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2952

Table 7 Comparison of the incidence of adverse reactions between the combined group and the B group

Citation: Zhao GG, Lou C, Gao RL, Lei FX, Zhao J. Combined use of dexmedetomidine and nalbuphine in laparoscopic radical gastrectomy for gastric cancer. World J Gastrointest Oncol 2024; 16(7): 2952-2959
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2952.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.2952